Clinical Trials
24
Active:5
Completed:3
Trial Phases
4 Phases
Phase 1:10
Phase 2:4
Phase 3:8
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (41.7%)Phase 3
8 (33.3%)Phase 2
4 (16.7%)Not Applicable
2 (8.3%)A Phase II Study of SKB571 in Patients With Lung Cancer
Not Applicable
Not yet recruiting
- Conditions
- Lung Cancer (Non-Small Cell)
- Interventions
- Drug: SKB571 for injection
- First Posted Date
- 2025-11-17
- Last Posted Date
- 2025-11-17
- Target Recruit Count
- 190
- Registration Number
- NCT07230405
- Locations
- 🇨🇳
Sun Yat-Sen University Cancer Center, Guangzhou, China
🇨🇳Henan Cancer Hospital, Zhengzhou, China
A Study of SKB107 in Advanced Solid Tumors With Bone Metastases
Not Applicable
Recruiting
- Conditions
- Metastatic Solid Tumors
- Interventions
- Drug: SKB107 for injection
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-09-02
- Target Recruit Count
- 90
- Registration Number
- NCT07087197
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
A Phase I Clinical Study of a Single Dose of KLA480
Phase 1
Recruiting
- Conditions
- Healthy Participants
- Interventions
- Drug: KLA480 injectionDrug: Placebo
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Target Recruit Count
- 20
- Registration Number
- NCT07030790
- Locations
- 🇨🇳
Huashan Hospital affiliated to Fudan University, Shanghai, Shanghai, China
A Study of SKB518 in Patients With Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Lung Carcinoma
- Interventions
- Drug: SKB518 for injection
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Target Recruit Count
- 80
- Registration Number
- NCT07019675
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Science, Beijing, China
SKB445 for Injection in Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: SKB445 for injection
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-03-17
- Target Recruit Count
- 126
- Registration Number
- NCT06826040
- Locations
- 🇨🇳
Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found